Zenith® fenestrert+ klinisk studie
Zenith® fenestrert+ endovaskulær graft klinisk studie
The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries.
Up to 130 additional subjects may be enrolled in Continued Access phase of the study
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Chanda Bell, RN, BSN
- Telefonnummer: 321506 765-463-7537
- E-post: chanda.bell@cookmedical.com
Studer Kontakt Backup
- Navn: Maria Soerensen
- Telefonnummer: +45 2868 3248
- E-post: maria.soerensen@cookmedical.com
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forente stater, 35294
- Rekruttering
- University of Alabama Birmingham Hospital
-
Ta kontakt med:
- Adam Beck, MD
-
-
California
-
La Jolla, California, Forente stater, 92037
- Rekruttering
- UC San Diego
-
Ta kontakt med:
- Mahmoud Malas, MD
-
Los Angeles, California, Forente stater, 90031
- Rekruttering
- University of Southern California
-
Ta kontakt med:
- Sukgu Han, MD
-
Stanford, California, Forente stater, 94305
- Rekruttering
- Stanford Hospitals and Clinics
-
Ta kontakt med:
- Jason Lee, MD
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forente stater, 20010
- Rekruttering
- Medstar Washington Hospital Center
-
Ta kontakt med:
- Steven Abramowitz, MD
-
-
Florida
-
Gainesville, Florida, Forente stater, 32610
- Rekruttering
- University of Florida Shands Hospital
-
Ta kontakt med:
- Zain Shahid, MD
-
Tampa, Florida, Forente stater, 33606
- Rekruttering
- Tampa General Hospital
-
Ta kontakt med:
- Dean Arnaoutakis, MD
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30322
- Rekruttering
- Emory University Hospital
-
Ta kontakt med:
- Yazan Duwayri, MD
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60611
- Rekruttering
- Northwestern Memorial Hospital
-
Ta kontakt med:
- Neel Mansukhani, MD
-
Glenview, Illinois, Forente stater, 60026
- Rekruttering
- Endeavor Health Cardiovascular Institute at Glenbrook Hospital
-
Ta kontakt med:
- George Pontikis
-
Maywood, Illinois, Forente stater, 60153
- Rekruttering
- Loyola University Medical Center
-
Ta kontakt med:
- Michael Soult, MD
-
Naperville, Illinois, Forente stater, 60540
- Rekruttering
- Edward Hospital
-
Ta kontakt med:
- George Pontikis, MD
-
Hovedetterforsker:
- George Pontikis, MD
-
-
Indiana
-
Indianapolis, Indiana, Forente stater, 46202
- Rekruttering
- Methodist Hospital of Indiana
-
Ta kontakt med:
- Andres Fajardo, MD
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21201
- Rekruttering
- University of Maryland
-
Ta kontakt med:
- Shahab Toursavadkohi, MD
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02215
- Rekruttering
- Beth Israel Deaconess Medical Center
-
Ta kontakt med:
- Marc Schermerhorn, MD
-
Boston, Massachusetts, Forente stater, 02114
- Fullført
- Massachusetts General Hospital
-
Worcester, Massachusetts, Forente stater, 01655
- Rekruttering
- University of Massachusetts
-
Ta kontakt med:
- Andres Schanzer, MD
-
-
Michigan
-
Ann Arbor, Michigan, Forente stater, 48109
- Rekruttering
- University of Michigan Health System
-
Ta kontakt med:
- Jonathan Eliason, MD
-
-
Minnesota
-
Rochester, Minnesota, Forente stater, 55905
- Rekruttering
- Mayo Clinic
-
Ta kontakt med:
- Randall DeMartino, MD
-
-
Missouri
-
St Louis, Missouri, Forente stater, 63110
- Rekruttering
- Barnes Jewish Hospital
-
Ta kontakt med:
- John Ohman, MD
-
-
New Hampshire
-
Lebanon, New Hampshire, Forente stater, 03756
- Rekruttering
- Dartmouth-Hitchcock Medical Center
-
Ta kontakt med:
- Bjoern Suckow, MD
-
-
New York
-
New York, New York, Forente stater, 10016
- Rekruttering
- New York University Langone Medical Center
-
Ta kontakt med:
- Thomas Maldonado, MD
-
New York, New York, Forente stater, 10032
- Rekruttering
- Columbia University Irving Medical Center/NY Presbyterian Hospital
-
Ta kontakt med:
- Virenda Patel
-
-
North Carolina
-
Chapel Hill, North Carolina, Forente stater, 27599
- Rekruttering
- University of North Carolina at Chapel Hill
-
Ta kontakt med:
- Federico Parodi, MD
-
-
Ohio
-
Cleveland, Ohio, Forente stater, 44195
- Rekruttering
- Cleveland Clinic Foundation
-
Ta kontakt med:
- Francis Caputo, MD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Rekruttering
- Hospital of the University of Pennsylvania
-
Ta kontakt med:
- Grace Wang, MD
-
Pittsburgh, Pennsylvania, Forente stater, 15213
- Rekruttering
- University of Pittsburgh Medical Center
-
Ta kontakt med:
- Nathan Liang
-
-
South Carolina
-
Charleston, South Carolina, Forente stater, 29425
- Rekruttering
- Medical University of South Carolina
-
Ta kontakt med:
- Ravi Veeraswamy, MD
-
-
Tennessee
-
Kingsport, Tennessee, Forente stater, 37660
- Rekruttering
- Holston Valley Hospital
-
Ta kontakt med:
- Robert "Bo" Allen, MD
-
-
Texas
-
Dallas, Texas, Forente stater, 75235
- Rekruttering
- Ut Southwestern
-
Ta kontakt med:
- Mirza Baig, MD
-
Houston, Texas, Forente stater, 77030
- Rekruttering
- Memorial Hermann Texas Medical Center/UT Health
-
Ta kontakt med:
- Naveed Saqib, MD
-
-
Virginia
-
Roanoke, Virginia, Forente stater, 24014
- Aktiv, ikke rekrutterende
- Carilion Roanoke Memorial Hospital
-
-
-
-
-
London, Storbritannia, SE1 7EH
- Aktiv, ikke rekrutterende
- St Thomas' Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Include Criteria:
- Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with a diameter ≥ 55 mm for males and ≥ 50 mm for females
- Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with a growth rate of ≥ 5 mm in 6 months
- Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with aortic diameter > 2x the normal aortic diameter or saccular aneurysm that warrants treatment in the opinion of the investigator
Exclusion Criteria:
- Age < 18 years
- Life expectancy < 2 years
- Pregnant, breast-feeding, or planning to become pregnant within 60 months
- Inability or refusal to give informed consent by the patient or legally authorized representative
- Unwilling or unable to comply with the follow-up schedule, required clinical assessments, and imaging
- Simultaneous participation in another investigation study, unless the patient is at least 30 days beyond the primary endpoint of any previous study
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Aorta abdominal aneurisme
|
Endovascular aneurysm repair |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Composite measure of device technical success and procedural safety
Tidsramme: 30 days post procedure
|
Percent of patients with device technical success and freedom from procedural safety events in the following criteria:
|
30 days post procedure
|
|
Composite measure of freedom from aneurysm-related mortality and clinically significant reintervention
Tidsramme: 12 months post procedure
|
Percent of patients meeting the following criteria:
|
12 months post procedure
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Gustavo Oderich, MD, Baylor College of Medicine
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- 17-07
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Cook Research Incorporated (CRI) is fully committed to supporting the principles of responsible data sharing, including providing qualified scientific researchers access to deidentified, patient-level data from CRI clinical studies to conduct legitimate scientific research. Data underlying the results reported in this clinical study will be made available for request after publication of the results from this study and ending 5 years after initial publication. Interested researchers may review the "Cook Research Incorporated Policy on Access to Clinical Study Data" at https://www.cookresearchinc.com/extranet/data-access.html and submit a complete research proposal to request data access. Additional study documents (such as the study protocol) will be shared as needed if the data access request is granted. A data sharing agreement will be executed for access to deidentified patient-level data.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .